COMP <GO>
MPT vs JPM // RSI-14 & 200D SMA MOMENTUM
Medical Properties Trust Inc. (NYSE) VS. JPMorgan Chase & Co. (NYSE) • 15-METRIC TALLY: MPT 2
— JPM 6
▲ RSI-14 & 200D SMA MOMENTUM LEADER: JPM
LAST: $2.44 (-11.27%) • MKT CAP: $1.46B
rsi-technicals
30.2
LAST: $343.58 (+1.26%) • MKT CAP: $913.30B
rsi-technicals
55.1
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MPT VS. JPM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MPT | JPM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -6.00% | 17.37% | -23.37 | JPM | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 9.7x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 15.84% | -18.14% | +33.98 | MPT | /fcf-yield <GO> |
| Operating Margin | — | 42.07% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -28.50% | 32.63% | -61.13 | JPM | /net-margins <GO> |
| Revenue Growth (YoY) | -2.40% | 13.53% | -15.93 | JPM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 1.96% | -1.96 | JPM | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 0.37 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 2/9 | +2.00 | MPT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 4.84% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 30.2 | 55.1 | -24.90 | JPM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.00 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 13.3x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.46B | $913.30B | -$911.84B | JPM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MPT REV | JPM REV | MPT GROSS % | JPM GROSS % | MPT FCF | JPM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $972.0M | $182.45B | — | — | $230.8M | -$147.78B |
| FY 2024 | $995.5M | $177.56B | — | — | $245.5M | -$42.01B |
| FY 2023 | $871.8M | $158.10B | — | — | $505.8M | $12.97B |
| FY 2022 | — | $128.69B | — | — | — | $107.12B |
| FY 2021 | — | $121.65B | — | — | — | $78.08B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MPT // BETA —
JPM // BETA 1.00